Evidence map›Paper›PMID 25510719›Full record

ArticleThe American journal of tropical medicine and hygiene2015

Malaria-related anemia in patients from unstable transmission areas in Colombia.

Mary Lopez-Perez, Álvaro Álvarez, Juan B Gutierrez, Alberto Moreno, Sócrates Herrera, Myriam Arévalo-Herrera

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mary Lopez-PerezCaucaseco Scientific Research Center, Cali, Colombia; Institute of Bioinformatics, University of Georgia, Athens, Georgia; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia; Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia; Faculty of Health, Universidad del Valle, Cali, Colombia.
Álvaro ÁlvarezCaucaseco Scientific Research Center, Cali, Colombia; Institute of Bioinformatics, University of Georgia, Athens, Georgia; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia; Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia; Faculty of Health, Universidad del Valle, Cali, Colombia.
Juan B GutierrezCaucaseco Scientific Research Center, Cali, Colombia; Institute of Bioinformatics, University of Georgia, Athens, Georgia; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia; Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia; Faculty of Health, Universidad del Valle, Cali, Colombia.
Alberto MorenoCaucaseco Scientific Research Center, Cali, Colombia; Institute of Bioinformatics, University of Georgia, Athens, Georgia; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia; Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia; Faculty of Health, Universidad del Valle, Cali, Colombia.
Sócrates HerreraCaucaseco Scientific Research Center, Cali, Colombia; Institute of Bioinformatics, University of Georgia, Athens, Georgia; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia; Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia; Faculty of Health, Universidad del Valle, Cali, Colombia.
Myriam Arévalo-HerreraCaucaseco Scientific Research Center, Cali, Colombia; Institute of Bioinformatics, University of Georgia, Athens, Georgia; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia; Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia; Faculty of Health, Universidad del Valle, Cali, Colombia marevalo@inmuno.org.
Emory University · USUniversity of Georgia · USCaucaseco Scientific Research Center · CO

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Vector Biology Research and Integrated Vector Management For Malaria ControlU19AI089702 · NIAID · CAUCASECO SCIENTIFIC RESEARCH CENTER · PI QUINONES, MARTHA · 2010 to 2016
$11.5M
Coadministration of capsid modified adenovirus for malaria vaccine developmentR21AI095718 · NIAID · EMORY UNIVERSITY · PI MORENO, ALBERTO · 2012 to 2013
$490k
Chimeric hybrid transmission blocking vaccine for malariaR21AI094402 · NIAID · EMORY UNIVERSITY · PI MORENO, ALBERTO · 2012 to 2013
$484k
NIAID NIH HHS 1U19AI089702NIAID NIH HHS R21 AI094402NIAID NIH HHS R21AI094402-01NIAID NIH HHS R21 AI095718NIAID NIH HHS R21AI095718-01NIAID NIH HHS U19 AI089702NIH HHS P51 OD011132
6 · The paper itself

Abstract

Information about the prevalence of malarial anemia in areas of low-malaria transmission intensity, like Latin America, is scarce. To characterize the malaria-related anemia, we evaluated 929 malaria patients from three sites in Colombia during 2011-2013. Plasmodium vivax was found to be the most prevalent species in Tierralta (92%), whereas P. falciparum was predominant in Tumaco (84%) and Quibdó (70%). Although severe anemia (hemoglobin < 7 g/dL) was almost absent (0.3%), variable degrees of non-severe anemia were observed in 36.9% of patients. In Tierralta, hemoglobin levels were negatively associated with days of illness. Moreover, in Tierralta and Quibdó, the number of previous malaria episodes and hemoglobin levels were positively associated. Both Plasmodium species seem to have similar potential to induce malarial anemia with distinct cofactors at each endemic setting. The target age in these low-transmission settings seems shifting toward adolescents and young adults. In addition, previous malaria experience seems to induce protection against anemia development. Altogether, these data suggest that early diagnosis and prompt treatment are likely preventing more frequent and serious malaria-related anemia in Colombia.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsAnemiaChildChild, PreschoolColombiaFemaleHemoglobinsHumansMalaria, FalciparumMalaria, VivaxMaleMiddle AgedHemoglobins

Identifiers

PMID25510719
PMCPMC4347332
OpenAlexW2312212105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.